This document is page 61 of a 'Cowen Collaborative Insights' report dated February 25, 2019, analyzing private companies in the CBD/hemp industry (Botanica, GenCanna, Highline Wellness, Lazarus Naturals, Lord Jones, and Mary's). While stamped 'HOUSE_OVERSIGHT_024877', indicating it is part of a larger document production (likely related to financial oversight), the page content itself is purely market research and contains no direct references to Jeffrey Epstein or his associates. The sidebar indicates the report was intended for Michael Cella at Cowen.
| Name | Role | Context |
|---|---|---|
| Michael Cella | Recipient |
Listed in the sidebar watermark as the intended recipient of the report at Cowen.
|
| Chris Roth | Co-founder of Highline Wellness |
Identified as a former Cowen alum.
|
| Chris D'Alberti | Business Partner |
Partner of Chris Roth at Highline Wellness.
|
| Robert Rosenheck | Founder |
Founder of Lord Jones.
|
| Cindy Capobianco | Founder |
Founder of Lord Jones.
|
| Name | Type | Context |
|---|---|---|
| Cowen | ||
| Botanica | ||
| GenCanna | ||
| MariMed | ||
| Highline Wellness | ||
| Lazarus Naturals | ||
| Lord Jones | ||
| Mary's | ||
| Mary's Medicinals | ||
| Mary's Nutritionals | ||
| Equinox | ||
| The Standard | ||
| Sephora |
"This report is intended for michael.cella@cowen.com. Unauthorized redistribution of this report is prohibited."Source
"In November 2018, MariMed (MRMD, not covered) invested $30 mm in GenCanna, which established a long-term supply agreement whereby GenCanna became MariMed's global hemp CBD supplier."Source
Complete text extracted from the document (4,078 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document